Johnson & Johnson: Diabetic Neuropathies trials
The registry lists 10 Diabetic Neuropathies studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 2 3Phase 3 5Phase 4 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic NeuralgiaCompletedNCT01124617Phase 2Results posted
- A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)TerminatedNCT01063868Phase 3Results posted
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral NeuropathyCompletedNCT01041859Phase 3Results posted
- A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic NeuropathyCompletedNCT00634543Phase 4Results posted
- A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral NeuropathyCompletedNCT00455520Phase 3Results posted
- Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With DiabetesCompletedNCT01235260
- A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful NeuropathyTerminatedNCT00993018Phase 2
- A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral PolyneuropathyCompletedNCT00231673Phase 2
- A Study Comparing the Effectiveness and Safety of Tramadol HCl/Acetaminophen Versus Placebo for the Treatment of Painful Neuropathy in Diabetic PatientsCompletedNCT00210847Phase 3
- A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEXTerminatedNCT00034788Phase 3